Comments
Loading...

Adaptimmune Therapeutics Stock News

ADAPNASDAQ
Logo brought to you by Benzinga Data
$0.2528
0.002801.12%
Pre-Market: 7:59 PM EDT
Q4 2024 Earnings were released on Thu Mar 20th, before the market open
The most recent conference call was at 8:00 AM, 6 days ago Click to view past webcast

Latest Adaptimmune Therapeutics Stock News | NASDAQ:ADAP | Benzinga

Get the latest news on Adaptimmune Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Adaptimmune Therapeutics performance